Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Gietema

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|April 2, 2003
[Thromboembolic complications during cisplatin-containing chemotherapy for testicular cancer: a problem in the short and possibly also the long term]J Nuver, J A Gietema
Nederlands Tijdschrift Voor Geneeskunde|July 14, 2016
[Docetaxel for metastatic prostate cancer: early is better]J A Gietema, S F Oosting
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 27, 2002
Clinical cancer research 2002: new agents and therapiesJ A Gietema, E G E de Vries
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Increased incidence of cardiovascular risk factors in cured testicular cancer patientsJ A Gietema, E G de Vries, D T Sleijfer
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2007
Follow-up of successfully treated testicular cancer patients: consequences of the metabolic syndromeE C de Haas, D Th Sleijfer, J A Gietema
European Journal of Cancer (Oxford, England : 1990)|June 13, 1998
Effects of gemcitabine on renal function in patients with non-small cell lung cancerJ A Gietema, H J Groen, S Meijer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 24, 2012
Pregnancy unbosoms the heart of breast cancer survivorsR Altena, J A Gietema, D J van Veldhuisen, et al.
Cell Death & Disease|April 22, 2011
Disruption of the MDM2-p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathwayR Koster, H Timmer-Bosscha, R Bischoff, et al.
Acta Oncologica (Stockholm, Sweden)|June 20, 2000
Seizures in a patient with disseminated testicular cancer due to cisplatin-induced hypomagnesaemiaA A van de Loosdrecht, J A Gietema, W T van der Graaf
Lancet (London, England)|February 24, 2001
Syndrome X in testicular-cancer survivorsJ A Gietema, M T Meinardi, W T van der Graaf, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Nederlands Tijdschrift Voor Geneeskunde|April 2, 2003
[Thromboembolic complications during cisplatin-containing chemotherapy for testicular cancer: a problem in the short and possibly also the long term]J Nuver, J A Gietema
Nederlands Tijdschrift Voor Geneeskunde|July 14, 2016
[Docetaxel for metastatic prostate cancer: early is better]J A Gietema, S F Oosting
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|November 27, 2002
Clinical cancer research 2002: new agents and therapiesJ A Gietema, E G E de Vries
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Increased incidence of cardiovascular risk factors in cured testicular cancer patientsJ A Gietema, E G de Vries, D T Sleijfer
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2007
Follow-up of successfully treated testicular cancer patients: consequences of the metabolic syndromeE C de Haas, D Th Sleijfer, J A Gietema
European Journal of Cancer (Oxford, England : 1990)|June 13, 1998
Effects of gemcitabine on renal function in patients with non-small cell lung cancerJ A Gietema, H J Groen, S Meijer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 24, 2012
Pregnancy unbosoms the heart of breast cancer survivorsR Altena, J A Gietema, D J van Veldhuisen, et al.
Cell Death & Disease|April 22, 2011
Disruption of the MDM2-p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathwayR Koster, H Timmer-Bosscha, R Bischoff, et al.
Acta Oncologica (Stockholm, Sweden)|June 20, 2000
Seizures in a patient with disseminated testicular cancer due to cisplatin-induced hypomagnesaemiaA A van de Loosdrecht, J A Gietema, W T van der Graaf
Lancet (London, England)|February 24, 2001
Syndrome X in testicular-cancer survivorsJ A Gietema, M T Meinardi, W T van der Graaf, et al.
Pageof 9